JUVENIA is a unique and innovative veterinary product based on Resveratrol and introduced through a new dosage vehicle: NUTRAGEL.
NUTRAGEL is a high palatability gel that, when added to food, makes the dog eat voraciously favoring the intake and facilitating continuity and adherence to treatment. In this manner, difficulties and traumas of the compulsory dosage of pills are eliminated.
JUVENIA DOGS can be used in all cases where it is necessary to increase and enhance the functions of defense, cognition, and metabolic actions of the organism, at any age and in any pathological process of deterioration or aging.
Recomended for puppies, healthy adults, or dogs with liver or kidney insufficiencies, heart failure, states of deep deterioration or high demand, convalescence, old age, and metabolic, infectious, or oncological diseases, etc.
A brief history of antioxidants
DECREASE OF THE SARCOPENIA, OSTEOPENIA AND DNA DAMAGE DUE TO OXIDATIVE STRESS IN DOGS, FOR THE SUPPLY OF A FOOD SUPPLEMENT BASED ON RESVERATROL*.
The supplementation with Resveratrol and -Tocopherol could reduce the risk of sarcopenia in dogs by counteracting the oxidative stress
Sauzul Pharma LLC in partnership with Microsules Argentina Laboratory
Microsules Laboratory is a pharmaceutical company of Argentine capitals with presence for more than 45 years producing a wide selection of high quality medicines.
In a highly competitive market, our company of Argentine capitals, have maintained a position of privilege thanks to the constant actualization of their equipment and the expertise of their professionals. This has allowed over time, to continue expanding and improving our product offering.
Actually, we provide three lines of products which are commercialized with their own sales force:
• Special treatments line (HIV - Oncology - Oncohematology)
• Pharma line (ambulatory medicines of high medical prescription)
• OTC line
We have a model pharmaceutical plant in Garin, province of Buenos Aires. In it we have a warehouse, areas of primary and secondary conditioning, quality controls and quality assurance with all the necessary equipment, a dinning area for employees and administration offices. Likewise, in December 2018 we enabled anew plant with more than de 2.000 square meters to elaborate injectable and lyophilized oncological products.
We are one of the laboratories which are leaders in the generic market. At this time, we commercialize more than 13.000.000 annual unities across the country with the possibility of expanding immediately according to the markets need.
We count with a staff of more than 180 people, which has been growing year after year to continue to provide an outstanding service according to the international standards.
In over 45 years of experience, we have always had the conviction that professionalization and constant actualization is the best way to improve the present and be prepared to upfront future challenges.